Review paper

Therapies for Alzheimer’s disease: a metabolic perspective

Volume: 132, Issue: 3, Pages: 162 - 172
Published: Mar 1, 2021
Abstract
Alzheimer’s disease (AD) is one of the most common forms of dementia in the elderly. Currently, there are over 50 million cases of dementia worldwide and it is expected that it will reach 136 million by 2050. AD is described as a neurodegenerative disease that gradually compromises memory and learning capacity. Patients often exhibit brain glucose hypometabolism and are more susceptible to develop type 2 diabetes or insulin resistance in...
Paper Details
Title
Therapies for Alzheimer’s disease: a metabolic perspective
Published Date
Mar 1, 2021
Volume
132
Issue
3
Pages
162 - 172
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.